Psychedelics Portland VA opens psychedelic therapy clinic for mental health and substance use disorders Two clinical trials are under way at the Social Neuroscience & Psychotherapy Lab Rowan DunneApril 2, 2024
Edibles Utah governor allows psychedelics pilot program without signature Republican Gov. Spencer Cox authorizes program despite reservations Zartasha MushtaqMarch 27, 2024
Psychedelics Alberta university kicks off major study on psilocybin for alcohol use disorder treatment Filament Health will supply psilocybin for what University of Calgary says is Canada's 'largest single-site clinical trial' of its kind Rowan DunneMarch 21, 2024
Psychedelics ATMA CENA opens Alberta psychedelic therapy clinics, Ontario locations to follow The treatment provider is a joint venture between ATMA Journey Centers and Cena Life Rowan DunneMarch 14, 2024
Psychedelics Controversial figure Dana Larsen gets his psychedelics business license back He had it suspended last May and his stores were raided by police in November, but it appears his perseverance has paid off Rowan DunneMarch 7, 2024
Psychedelics Incannex and partner Clarion open Australia’s first psychedelic therapy clinic in Melbourne Mind Medicine Australia legally dosed the first patients outside of clinical trials in over 50 years last month Rowan DunneFebruary 1, 2024
Health & Wellness Compass Pathways, Hackensack Meridian Health collaborate on psilocybin treatment research Partnership signals a milestone agreement for innovative treatment solutions Zartasha MushtaqJanuary 19, 2024
Psychedelics Filament Health ships psilocybin drug to Australia, first country legally prescribing psychedelics The shipment was received by the medical cannabis company Little Green Pharma and its psychedelics subsidiary Rowan DunneJanuary 17, 2024
Psychedelics MAPS subsidiary raises over US$100M to support MDMA regulation The funding was led by the non-profit Helena, a diverse organization that aims to solve global problems Rowan DunneJanuary 5, 2024
Science and Research DEA sharply increases quantities of psychedelics, cannabinoids for 2024 research Substances being produced at a more rapid rate this year will include psilocybin, DMT and delta-9 THC Rowan DunneJanuary 4, 2024